Are These Stocks Still Magnificent?

Is it time to move on from the so-called Magnificent Seven? ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

AN OXFORD CLUB PUBLICATION

View in browser SPONSORED **URGENT AI BIOTECH EVENT** In the coming days, an AI biotech - currently trading for less than $10 - is expected to make a bombshell announcement. And I do mean BOMBSHELL. These announcements have historically been known to generate FAR more explosive gains than FDA approval... and in a MUCH shorter time... As much as 509% MORE gains in some cases. Companies that have made similar announcements have seen their shares positively SOAR. And on June 27 at 2 p.m. ET, America's #1 stock catalyst expert wants to give you all the details. Including why this coming announcement could be bigger and more important than anything we've seen in a lifetime. Claim a free spot to attend right here. EDITOR'S NOTE Artificial intelligence (AI) is surging. That's why Alexander Green is telling his readers to buy a handful of AI stocks "before the end of the month." He says $1,000 in each of these stocks could be worth over $1 million in less than six years. Get the details on all of what Alex calls "The Next Magnificent Seven" right here. - Nicole Labra, Senior Managing Editor THE SHORTEST WAY TO A RICH LIFE Are These Seven Stocks Still Magnificent? Matt Benjamin, Senior Markets Expert, The Oxford Club Trees don't grow to the sky. It's a translation of an old German expression that conveys the idea that there are natural limits to growth. And the bigger a thing grows, the slower its rate of growth will become. Trees, of course, are the perfect example of this. Though, stocks tend to act this way as well. Small cap stocks have historically outperformed large caps. This is because small companies have more room to grow and can generate rapid revenue and profit growth. And stocks with very large capitalizations (in particular) start to decelerate as their valuations - the ratio of their price to their earnings - get stretched. This makes them more expensive compared to their peers. We're seeing exactly that right now with the famous "Magnificent Seven" stocks. These are the seven tech behemoths that have garnered investor enthusiasm over the past eighteen months due to their association with artificial intelligence (AI) - and the potential it has to generate mega profits. But many of these seven stocks seem to have entered a mini correction over the past few weeks (though some of them started correcting much earlier), suggesting that they'll begin to rise more slowly. This can be expected - at least temporarily - until their earnings can catch up with their sky-high share prices. SPONSORED Could You Wake Up Tomorrow to Big Gains? This Chicago Board Options Exchange veteran is set to blow the whistle on Wall Street's best kept secret. People just like you are waking up to gains as high as 108%... 133%... 150%... and even 188% thanks to these Overnight Trades. If you want the chance to make Overnight Trades for yourself... You need to see THIS now. King of Semiconductors The reigning champion of the Magnificent Seven is AI chipmaker Nvidia (Nasdaq: NVDA) - its stock price rose from $11 in late 2022 to $136 in mid-June. And it has since corrected sharply. The stock tumbled 12% over the past week, shedding a whopping $400 billion from its market capitalization. That course correction began right after the company became the most expensive stock in the S&P 500. Here are the other six of the Magnificent Seven's recent performances: Alphabet (Nasdaq: GOOG) peaked on May 21 and has been trading sideways since then. Apple (Nasdaq: AAPL) peaked on June 17 and is down 3%. Amazon (Nasdaq: AMZN) peaked on May 9 and is down 2%. Tesla (Nasdaq: TSLA) is having a tough 2024 - it's down 26% for the year. Microsoft (Nasdaq: MSFT) has been trading sideways since June 17. Meta Platforms (Nasdaq: META) peaked in early April and is now 4% off its high. And here's an index of the seven stocks, the Roundhill Magnificent Seven ETF (Nasdaq: MAGS), and its performance year to date... Changing of the Guard I'm not suggesting these stocks are in a permanent decline. Far from it - they're all well-run companies with valuable, proven business models. And AI does seem to be the technology of the future - which is why I'm glad to have several of these stocks in my own portfolio. But as their prices rise and their valuations stretch - Nvidia's forward price-to-earnings ratio has grown from 25 late last year to 45 today - smart investors should be looking for newer companies to add to their portfolios for a new bout of rapid growth. So, if you didn't invest in the Magnificent Seven last year, don't fret. There will be plenty of companies that benefit enormously from AI and other technologies going forward. In fact, Alexander Green has discovered what he calls "the Next Magnificent Seven" - these are relatively-unknown AI super stocks that are set to dominate the markets going forward. You can find all the details here. But don't wait. Make sure you own these stocks before they soar. [Editor's Note: Since Matt wrote this piece on Monday afternoon, the Magnificent Seven stocks have rallied a bit to take back recent losses. But the idea is the same: they've become extremely expensive relative to the broader market - and there are many other AI-related stocks that savvy investors should consider buying now while they're still cheap.] Invest wisely, Matt Leave a Comment BUILD AND PROTECT YOUR WEALTH How to Profit From the Surge (Outside the Stock Market)... Click Here. My Favorite Pattern + Special Announcement The Oxford Club's #1-Ranked VIP Trading Service Beat the Relative S&P by 592% Since 2001. See How to Get a Free Year Here. Punch Buggy Takes Action... JOIN THE CONVERSATION Facebook LinkedIn Email Share MORE FROM LIBERTY THROUGH WEALTH The Sweet Spot to Invest in the Biotech Sector How Shareholders - Like You - are Public Benefactors This Father's Biggest Wish The Key to Finding Winners in the AI Craze SPONSORED Nvidia's Secret Partner... This Is The New AI Chip Powerhouse I bet you've never heard of it... but this newly public company is set to become key to Nvidia's seat on the AI throne. And for now... you can get in while it's still cheap. Details Here! You are receiving this email because you subscribed to Liberty Through Wealth. Liberty Through Wealth is published by The Oxford Club. Questions? Check out our FAQs. Trying to reach us? Contact us here. Please do not reply to this email as it goes to an unmonitored inbox. Privacy Policy | Whitelist Liberty Through Wealth | Unsubscribe © 2024 The Oxford Club, LLC All Rights Reserved The Oxford Club | 105 West Monument Street | Baltimore, MD 21201 North America: 877.806.4508 | International: +1.443.353.4610 Oxfordclub.com Nothing published by The Oxford Club should be considered personalized investment advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed personalized investment advice. We allow the editors of our publications to recommend securities that they own themselves. However, our policy prohibits editors from exiting a personal trade while the recommendation to subscribers is open. In no circumstance may an editor sell a security before subscribers have a fair opportunity to exit. The length of time an editor must wait after subscribers have been advised to exit a play depends on the type of publication. All other employees and agents must wait 24 hours after publication before trading on a recommendation. Any investments recommended by The Oxford Club should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. The information found on this website may only be used pursuant to the membership or subscription agreement and any reproduction, copying or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of The Oxford Club, LLC, 105 West Monument Street, Baltimore, MD 21201.